{
    "2020-01-07": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Is Biogen Stock A Buy On Renewed Hope In Alzheimer's Disease?",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Alzheimer's Disease",
                        "renewed hope"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Why Bank of America expects the hot European pharmaceuticals sector to stumble — and it’s not a fear of U.S. drug prices",
                "features": {
                    "keywords": [
                        "Bank of America",
                        "European pharmaceuticals",
                        "stumble",
                        "U.S. drug prices"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}